财新传媒
财新英文 > 要闻 > 正文

‘Capital Winter’ Chills Investment in China’s Health Care Industry

By Hua Ang, Zhou Xinda and Wang Xintong
2023年10月25日 20:51
Data shows funding for the sector continues to decline from its 2021 peak, plummeting to $5.7 billion in the first half of 2023

China’s cutting-edge drug developers are feeling the pinch from a continued contraction in investment, with some having to make massive layoffs or abandon non-core businesses to survive what has been dubbed a “capital winter.”

  [财新双语通产品,是为有双语需求读者专门订制的优惠产品, 按此可享超值优惠订阅。]

版面编辑:喻竹杨洋
财新网主编精选版电邮 样例
财新网新闻版电邮全新升级!财新网主编精心编写,每个工作日定时投递,篇篇重磅,可信可引。
订阅